Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
Figure 9
(a) Comparison of patient global assessment of disease activity between iguratimod and placebo groups. (b) Comparison of patient global assessment of disease activity between iguratimod and other DMARDs (MTX and SASP) groups.
